Does RISANKIZUMAB-RZAA Cause C-reactive protein abnormal? 13 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of C-reactive protein abnormal have been filed in association with RISANKIZUMAB-RZAA. This represents 0.0% of all adverse event reports for RISANKIZUMAB-RZAA.
13
Reports of C-reactive protein abnormal with RISANKIZUMAB-RZAA
0.0%
of all RISANKIZUMAB-RZAA reports
0
Deaths
3
Hospitalizations
How Dangerous Is C-reactive protein abnormal From RISANKIZUMAB-RZAA?
Of the 13 reports, 3 (23.1%) required hospitalization.
Is C-reactive protein abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause C-reactive protein abnormal?
METHOTREXATE (3,734)
ADALIMUMAB (3,629)
ETANERCEPT (3,592)
ABATACEPT (3,402)
LEFLUNOMIDE (3,279)
TOCILIZUMAB (3,259)
HYDROXYCHLOROQUINE (3,245)
SULFASALAZINE (2,823)
INFLIXIMAB (2,676)
RITUXIMAB (2,608)
Which RISANKIZUMAB-RZAA Alternatives Have Lower C-reactive protein abnormal Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA